<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01061203</url>
  </required_header>
  <id_info>
    <org_study_id>GT-21</org_study_id>
    <nct_id>NCT01061203</nct_id>
  </id_info>
  <brief_title>Grazax Asthma Prevention</brief_title>
  <acronym>GAP</acronym>
  <official_title>Grazax Asthma Prevention</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>ALK-Abelló A/S</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>ALK-Abelló A/S</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Investigation of the effect of Grazax (grass tablet) on asthma prevention in children with
      grass pollen allergy
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Investigation of the effect of Grazax (ALK produced grass tablet) on asthma prevention in
      children with grass pollen allergy.

      Children in the age of 6-12 years will be randomised to either placebo or Grazax treatment.
      Grazax has been approved for treatment of grass pollen allergy in adults and children,
      diagnosed with a positive skin prick test and/or specific immunoglobulin (IgE) test to grass
      pollen and with clinically relevant symptoms. This study will explore prevention of asthma in
      children with grass pollen induced allergy.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2010</start_date>
  <completion_date type="Actual">September 2015</completion_date>
  <primary_completion_date type="Actual">September 2015</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluation of allergy and asthma symptoms</measure>
    <time_frame>5 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of life and adverse events</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">812</enrollment>
  <condition>Allergic Rhinitis</condition>
  <arm_group>
    <arm_group_label>Grazax</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Grazax tablet 75.000 SQ-T. One tablet per day for administration under the tongue.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Tablet with no active grass</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Tablet with no active grass component. One tablet per day administered under the tongue.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Grazax</intervention_name>
    <description>Treatment with 75.000 SQ-T once daily</description>
    <arm_group_label>Grazax</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Tablet with no active grass component.</description>
    <arm_group_label>Tablet with no active grass</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  A history of grass pollen allergy

          -  Positive Skin prick test to grass

          -  Positive specific IgE to grass

        Exclusion Criteria:

          -  Asthma
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>5 Years</minimum_age>
    <maximum_age>12 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Erkka Valovirta, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Terveystalo Turku, Finland</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Terveystalo Turku</name>
      <address>
        <city>Turku</city>
        <zip>20100</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 1, 2010</study_first_submitted>
  <study_first_submitted_qc>February 1, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 3, 2010</study_first_posted>
  <last_update_submitted>September 7, 2016</last_update_submitted>
  <last_update_submitted_qc>September 7, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 8, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Rhinitis</keyword>
  <keyword>allergic</keyword>
  <keyword>Seasonal</keyword>
  <keyword>grass</keyword>
  <keyword>Asthma</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rhinitis</mesh_term>
    <mesh_term>Rhinitis, Allergic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

